Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Solid Tumors 1Breast Neoplasms 1

Interventions

Paclitaxel 5Capecitabine 5pyrotinib 4Epirubicin 4Docetaxel 4exemestane 3Vinorelbine 3Radiotherapy 3Radiation Dose Hypofractionation 3Fulvestrant 3Carboplatin 3apatinib 2Neoadjuvant Therapy 2Letrozole 2Etoposide 2Cyclophosphamide 2Albumin-Bound Paclitaxel 2toripalimab 1titanium silicide 1pirarubicin 1palbociclib 1nimotuzumab 1icaritin 1anlotinib 1Therapeutics 1Standard of Care 1Radiation 1Pemetrexed 1Nutrition Assessment 1Methods 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Breast Neoplasms × icaritin × Clear all
NCT01278810 2011-01-28

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

ChineseAMS

Phase 1 Unknown
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡